Vaccinations are an important factor in containing the COVID-19 pandemic and make a safe return to campus possible. TUM students and staff can now be vaccinated without pre-registration on campus at fixed dates in July, August and October.
Current Covid-19 news
Current news from TUM about Covid-19 and the coronavirus Sars-CoV2: How we are researching solutions, informing the public and advising politics, supporting society with our own initiatives - and how we are keeping university operations running during this pandemic.
Older people with economic difficulties and a low level of education more frequently refuse to be vaccinated against Covid-19 than individuals with a good income and higher level of education. These observations are the result of a pan-European study of people aged 50 years and older conducted by a Munich research team. According to the study, there is a high rate of vaccination uncertainty across most of the Eastern European and Baltic states in comparison to the West, South and North European regions.
Using telemedicine, COVID-19 patients can be cared for safely at home – from initial home isolation to recovery or, in case problems arise, admission to hospital. A team from the Technical University of Munich (TUM) has now successfully demonstrated this in a study involving 150 patients with risk factors for a severe progression of the disease.
In their Covid-19 Lecture, Prof. Clarissa Prazeres da Costa and Dr. Nina Wantia of the Institute of Medical Microbiology, Immunology and Hygiene show how hospitals had to act quickly and extensively to protect patients and staff from infection with Sars-CoV2. The two also look back at past pandemics and discuss how looking back at the past helps to better master a current situation.
The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical University of Munich (TUM) – has now compiled the most detailed view of the virus' protein structures available to date. The analysis employing artificial intelligence methods has revealed surprising findings.
According to Prof. Gerhard Müller, Senior Vice President for Academic and Student Affairs at the Technical University of Munich (TUM), the new corona regulations of the state of Bavaria provide a solid foundation for in-person instruction in the winter semester. At a joint press conference today with Bavaria's Minister of Science Bernd Sibler, Müller called on students to "Come back to campus!" The so-called 3G rule, according to which students must be vaccinated, recovered, or tested in order to attend classes in person, forms an essential building block of the university's planning, he said.
T cells play a decisive role in fighting the coronavirus and preventing infected individuals from becoming seriously ill. They identify and fight the virus directly within the infected cells. A team of researchers working in Munich have produced a precise profile of the T cells that respond to SARS-CoV-2 and described them at various stages of the illness. This novel methodological approach may in the future also help to assess the efficacy of SARS-CoV-2 vaccines or in the development of T cell-based treatments for serious cases. It may also offer hope for other illnesses such as cancer or autoimmune diseases.
People under the age of 60 who initially received a vaccine from AstraZeneca should be given an mRNA vaccine at their second appointment. This is recommended by the German Standing Committee on Vaccination. However, up until now, there were no data available to indicate to what extent the human organism would react to such a mix-and-match vaccination and start to form antibodies. A team of researchers has now proven that the antibody response is much stronger with the mix-and-match vaccine than with two doses of the AstraZeneca vaccine.
To date, there are no effective antidotes against most virus infections. An interdisciplinary research team at the Technical University of Munich (TUM) has now developed a new approach: they engulf and neutralize viruses with nano-capsules tailored from genetic material using the DNA origami method. The strategy has already been tested against hepatitis and adeno-associated viruses in cell cultures. It may also prove successful against corona viruses.
Why have stock prices rebounded so quickly during the pandemic? What insights have researchers gained on capital markets during the crisis? In this interview, Prof. Christoph Kaserer gives a preview of his public Covid-19 Lecture that he will give online on Wednesday, July 14 at 6:15 pm.
During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies – either through infection or vaccination. Researchers at the Technical University of Munich (TUM) have now developed such a rapid antibody test. It provides the result in only eight minutes; the aim is to further reduce the process time to four minutes.